Merja Soilu-Hänninen
MD, PhD
Turku University Hospital, Division of Clinical Neurosciences mersoi@utu.fi |
Clinical neurology; neuroimmunology; multiple sclerosis risk factors, prognostic factors and treatment
MD, University of Turku 1988
PhD, University of Turku, Department of Virology, Immunobiology of central nervous system virus infections 1996
Postdoctoral Fellow, Development and Neurobiology Group, The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia 1997-1999
Specialist Degree in Neurology 2001
Adjuct Professor of Clinical Neurology 2008
Inverstigator in several clinical MS trials
Chair of the Finnish MS registry 2016-
General Neurology Section Head, Turku University Hospital, Division of Clinical Neurosciences 2017-
Multiple sclerosis risk factors, prognostic factors and epidemiology.
Imaging of brain atrophy in multiple sclerosis.
Course of medical pedagogics 2011-2012
Supervisor of several PhD student
- Parechovirus infection preceding Guillain–Barré syndrome (2012)
- Journal of NeuroVirology
- Unenaikainen kohtauksellinen tukehtumisen tunne - diagnostinen haaste (2012)
- Duodecim
- Simvastatin as add-on therapy to interferon B-1a for relapsing-remitting multiple sclerosis (SIMCOMBIN study): a placebo-controlled randomised phase 4 trial (2011)
- Lancet Neurology
- CHARACTERIZATION OF CD4+T CELLS SPECIFIC FOR GLUTAMIC ACID DECARBOXYLASE (GAD65) AND PROINSULIN IN A PATIENT WITH EPILEPSY AND STIFF-PERSON SYNDROME, BUT WITHOUT TYPE 1 DIABETES (2010)
- Epilepsia
- Characterization of CD4+ T cells specific for glutamic acid decarboxylase (GAD65) and proinsulin in a patient with stiff-person syndrome but without type 1 diabetes (2010)
- Diabetes/Metabolism Research and Reviews
- C-reactive protein and seizure in focal epilepsy: Avideo-EEG study (2010)
- Epilepsia
- Expression of LIF and LIF receptor beta in Alzheimer's and Parkinson's diseases (2010)
- Acta Neurologica Scandinavica
- Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosis (2010)
- Journal of the Neurological Sciences
- T2-weighted high-intensity signals in the basal ganglia as an interesting image finding in Unverricht-Lundborg disease (2010)
- Epilepsy Research
- Hyaluronate receptor (CD44) and integrin α4 (CD49d) are up-regulated on T cells during MS relapses (2005)
- Journal of Neuroimmunology
- Molecular mechanisms regulating motor neuron development and degeneration (1999)
- Molecular Neurobiology
- New treatments for multiple sclerosis (1999) Kilpatrick T., Soilu-Hänninen M.
- Semliki Forest virus infection leads to increased expression of adhesion molecules on splenic T-cells and on brain vascular endothelium (1997)
- Journal of NeuroVirology
- Interferon-β downregulates expression of VLA-4 antigen and antagonizes interferon-γ-induced expression of HLA-DQ on human peripheral blood monocytes (1995)
- Journal of Neuroimmunology
